News
7 May 2026
Venus Remedies Secures its First Marketing Authorization in Argentina, Expands Latin America Footprint
Venus Remedies Limited (NSE: VENUSREM, BSE: 526953) has secured marketing authorization from Argentina’s national regulatory authority for its antibiotic, Ceftriaxone.…
